3.1.4.41	4-bromo-N-[(E)-(2-methyl-1H-indol-3-yl)methyleneamino]benzenesulfonamide	uncompetitive inhibitor	231459	
3.1.4.41	4-methyl-3-oxo-2-(3-pyridylmethylene)benzo[3,4-b]furan-6-yl 4-chloro-benzenesulfonate	mixed-type inhibitor	231479	
3.1.4.41	6-amino-2-((4-cyanobenzyl)thio)pyrimidin-4-yl 4-methylbenzenesulfonate	uncompetitive inhibitor	231642	
3.1.4.41	Ca2+	-	15	
3.1.4.41	diethyldicarbonate	0.02-0.1 mM, complete inhibition, sphingomyelinase P1; 0.02-0.1 mM, complete inhibitionsphingomyelinase P2	310	
3.1.4.41	EDTA	strong	21	
3.1.4.41	EDTA	-	21	
3.1.4.41	Hg2+	-	33	
3.1.4.41	additional information	enzyme induced human platelet aggregation is inhibited by EDTA over a range of 0.6 to 3.0 mM	2	
3.1.4.41	additional information	inhibition of erythrocyte lysis by staphylococcal beta-haemolysin	2	
3.1.4.41	additional information	-	2	
3.1.4.41	additional information	enzyme activity is blocked by the anti-loxoscelic antivenom	2	
3.1.4.41	phosphatidylinositol-3,5-bisphosphate	-	165762	
3.1.4.41	Zn2+	-	14